Gasdermin-D Genetic Knockout Reduces Inflammasome-Induced Disruption of the Gut-Brain Axis After Traumatic Brain Injury
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083512 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Erika D L R M Cabrera Ranaldi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery and The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Inflammasomes, Phosphate-Binding Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NINDS/NIA.
Abstract (Originalsprache)
Traumatic brain injury (TBI) pathology is significantly mediated by an inflammatory response involving inflammasome activation, resulting in the release of interleukin (IL)-1β and pyroptotic cell death through gasdermin-D (GSDMD) cleavage. Inflammasome components are transported through extracellular vesicles (EVs) to mediate systemic inflammation in peripheral organs, including the gut. The purpose of this study was to determine the protective effect of GSDMD knockout (KO) on TBI-induced inflammasome activation, EV signaling, and gut function. GSDMD-KO and C57BL6 (WT) mice were subjected to the controlled cortical impact model of TBI. Cytokine expression was assessed with electrochemiluminescent immunoassay and immunoblotting of the cerebral cortex and gut. EVs were examined for pathology-associated markers using flow cytometry, and gut permeability was determined. GSDMD-KO attenuated IL-1β and IL-6 expression in the cerebral cortex and reduced IL-1β and IL-18 in the gut 3 days post-injury. GSDMD-KO mice had decreased neuronal- and gut-derived EVs compared to WT mice post-TBI. GSDMD-KO EVs also had decreased IL-1β and different surface marker expression post-TBI. GSDMD-KO mice had decreased gut permeability after TBI. These data demonstrate that GSDMD ablation improves post-TBI inflammation and gut pathology, suggesting that GSDMD may serve as a potential therapeutic target for the improvement of TBI-associated pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery and The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Bruce W. Carter Department of Veteran Affairs Medical Center, Miami, FL 33136, USA.
- Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
- Department of Cellular Physiology and Molecular Biophysics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
ORCID-Profile: Erika D L R M Cabrera Ranaldi, Oliver Umland, Juan Pablo de Rivero Vaccari
Förderung
- NINDS NIH HHS
- NIH HHS
- NINDS/NIA
- NIH/NINDS
- NINDS
Zitieren
APA
Cabrera Ranaldi, E. D. L. R. M., Bramlett, H. M., Umland, O., Levine, L. I., Keane, R. W., de Rivero Vaccari, J. P., Dietrich, W. D., & Kerr, N. A. (2025). Gasdermin-D Genetic Knockout Reduces Inflammasome-Induced Disruption of the Gut-Brain Axis After Traumatic Brain Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083512
Vancouver
Cabrera Ranaldi EDLRM, Bramlett HM, Umland O, Levine LI, Keane RW, de Rivero Vaccari JP, et al. Gasdermin-D Genetic Knockout Reduces Inflammasome-Induced Disruption of the Gut-Brain Axis After Traumatic Brain Injury. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083512
BibTeX
@article{CabreraRanaldi2025,
author = {Cabrera Ranaldi, Erika D L R M and Bramlett, Helen M and Umland, Oliver and Levine, Leo I and Keane, Robert W and de Rivero Vaccari, Juan Pablo and Dietrich, W Dalton and Kerr, Nadine A},
title = {Gasdermin-D Genetic Knockout Reduces Inflammasome-Induced Disruption of the Gut-Brain Axis After Traumatic Brain Injury},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083512}
}
EUVIMED